Relavo

Baltimore, United States

Relavo offers a device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease.

$500K raised

Apr 2023

Seed

Top Investors

National Science FoundationMassChallengeEmmeline VenturesNational Kidney FoundationSan Diego Angel Conference

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Relavo raised?

Relavo has raised $500K in total funding. The most recent round was Seed. The last funding was announced in April 2023.

Who are Relavo's investors?

Relavo's investors include National Science Foundation, MassChallenge, Emmeline Ventures, National Kidney Foundation, San Diego Angel Conference.

Where is Relavo headquartered?

Relavo is headquartered in Baltimore, United States.

What does Relavo do?

Relavo offers a device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease.

What stage is Relavo at?

Relavo is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 4, 2023.

MLA

"Relavo — Funding & Investors." VCBacked, April 4, 2023, https://www.vcbacked.co/company/relavo. Accessed June 3, 2026.

APA

VCBacked. (2023). Relavo — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/relavo

Wikipedia (cite web)

{{cite web |title=Relavo — Funding & Investors |url=https://www.vcbacked.co/company/relavo |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 4, 2023.